According to BioCryst Pharmaceuticals
's latest financial reports the company's current revenue (TTM ) is A$0.64 Billion. In 2023 the company made a revenue of A$0.48 Billion an increase over the revenue in the year 2022 that were of A$0.39 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 (TTM) | A$0.61 B | 25.82% |
2023 | A$0.48 B | 22.23% |
2022 | A$0.39 B | 83.58% |
2021 | A$0.21 B | 835.87% |
2020 | A$23.16 M | -66.79% |
2019 | A$69.75 M | 137.92% |
2018 | A$29.31 M | -9.13% |
2017 | A$32.26 M | -11.76% |
2016 | A$36.55 M | -44.81% |
2015 | A$66.24 M | 298.39% |
2014 | A$16.62 M | -14.42% |
2013 | A$19.42 M | -23.21% |
2012 | A$25.3 M | 32.07% |
2011 | A$19.15 M | -68.81% |
2010 | A$61.41 M | -26.04% |
2009 | A$83.03 M | 3.57% |
2008 | A$80.17 M | -1.61% |
2007 | A$81.48 M | 934.18% |
2006 | A$7.87 M | 3696.08% |
2005 | A$0.2 M | 1704.46% |
2004 | A$0.01 M | -99.48% |
2003 | A$2.19 M | -30.21% |
2002 | A$3.14 M | -85.59% |
2001 | A$21.86 M | 972.64% |
2000 | A$2.03 M | -50.27% |
1999 | A$4.09 M | -61.98% |
1998 | A$10.77 M | 485.21% |
1997 | A$1.84 M | -43.72% |
1996 | A$3.27 M |